Amida Launches TorQE, a Pre-Submission Medicaid Data Validation Platform for State Agencies

Article content

TorQE helps states validate T-MSIS data before submission, identify defects early, and reduce reactive remediation after federal review

Article content

WASHINGTON — Amida Technology Solutions, Inc. (Amida) today announced the launch of TorQE, a pre-submission Medicaid data validation platform for state agencies. The platform helps states review Transformed Medicaid Statistical Information System (T-MSIS) files before submission to the Centers for Medicare and Medicaid Services (CMS). TorQE applies more than 1,900 validation rules aligned with the Outcomes Based Assessment (OBA) framework so agencies can identify and address defects proactively.

Article content

Article content

Article content

Today, T-MSIS processes follow a reactive model. Data quality defects often surface after CMS completes its OBA evaluation, and feedback can arrive after the submission window closes. By then, errors may already appear in federal review materials. Remediation can require resubmission, rework, and additional staff time. CMS now places greater emphasis on timely, accurate, and complete T-MSIS data, connecting these standards to Certification Review readiness.

Article content

Article content

TorQE moves quality control upstream. States can upload data to the platform three to four weeks before their filing deadline. TorQE runs CMS-aligned OBA validation across T-MSIS files and applies cross-file consistency checks that siloed tools can miss. The platform identifies record-level defects and pairs them with root-cause analysis. Teams can see which records fail, the underlying cause, and which upstream fixes address the largest error clusters. Structured remediation workflows replace spreadsheet and email processes. A submission readiness dashboard gives compliance officers a forward view of likely OBA performance before files reach CMS.

Article content

“State Medicaid agencies need earlier visibility into T-MSIS quality,” said Pradeep Peddineni, director of product development at Amida. “Too often, teams submit data, wait for CMS feedback, and correct defects after the fact. TorQE changes that timeline. When agencies can see likely OBA performance before submission, they can resolve issues in time.”

Article content

TorQE addresses a regulatory environment in which agencies face rising expectations for T-MSIS submissions. CMS uses OBA methodology to evaluate these files; its guidance also emphasizes data accuracy, completeness, and timeliness for Medicaid and CHIP programs. Certification materials further require states to confirm T-MSIS compliance and demonstrate measurable progress against program targets. TorQE gives agency leaders a documented record of defects, fixes, trends, and remediation activity.

Article content

“T-MSIS is more than a data submission requirement, it is a federal performance signal,” said Peter L. Levin, co-founder and chief innovation officer. “States that rely on reactive oversight carry added compliance risk as CMS increases its focus on T-MSIS data quality. TorQE gives agencies a structured, OBA-aligned validation process and a clear, defensible evidence trail.”

Article content

Article content

Amida developed TorQE with state Medicaid data teams who experience the limitations of traditional T-MSIS quality control. It is cloud-agnostic, integrates with existing agency infrastructure, and is available as a standalone solution.

Article content

About Amida

Article content

Amida Technology Solutions, Inc. is an industry leader that solves the most complex challenges in data interoperability, data exchange, data governance, and data security. Amida delivers advanced data-engineering, AI/ML, and cybersecurity solutions that transform complex data into trusted, actionable insight. The company’s suite of platforms power systems for clients in healthcare, defense, and critical infrastructure. For more information, visit www.amida.com.

Article content

Article content

Article content

Article content

View source version on businesswire.com:

Article content

Article content

Article content

Contacts

Article content

Media Contact

Article content

Article content

Peter L. Levin

Article content

Article content

202-735-1798

Article content

Article content

Article content